11:20 AM EDT, 09/13/2024 (MT Newswires) -- Autolus Therapeutics ( AUTL ) agreed to amend its lease deal with the landlord of its Nucleus manufacturing facility in Stevenage, UK.

The amendment covers up to 18.5 million pounds ($24.3 million) for facility improvements by the landlord, Forge Life Sciences nominees, and an annual rent increase of up to 2.19 million pounds, subject to certain terms, Autolus Therapeutics ( AUTL ) said Friday in a regulatory filing.

The amendment won't affect the lease term, which runs through September 2043.

Price: 3.98, Change: +0.03, Percent Change: +0.76